glp-1 law firm Agenda New York Ozempic & GLP-1
Description
QD, One time a day
Several SURMOUNT studies in patients with obesity are ongoing ( In the SURPASS-1 study, which enrolled 705 non-target T2DM patients with diet and physical activity intervention, the efficacy, safety, and tolerability of tirzepatide and a placebo were compared
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderatetosevere chronic kidney disease (AWARD7): a multicentre, openlabel, randomised trial
doi: 10.1056/NEJMoa1504720 4 NealBPerkovicVMahaffeyKWde ZeeuwDFulcherGEronduNet al
Personalized programs allow for dosage adjustments based on how your body is actually responding
Compounded versions through pharmacies like Belmar and Direct Meds offer lower-cost options
